Ronald Fiore, MD
Neurology · New Orleans, LANPI 1548205362
Payments from drug & device makers
Across 769 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- UCB, Inc.$922
- Acadia Pharmaceuticals Inc$871
- Eisai Inc.$858
- Teva Pharmaceuticals USA, Inc.$628
- Pfizer$586
- plus $6K from 40 others
What the payments were for
- Speaking & faculty fees$170%
- Food & beverage$11,10996%
- Education$3913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$11,516 in reported general payments places this provider in the 70th percentile of 225 neurology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 76 | $960,940 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 25 | $394,096 |
| NuplazidPimavanserin Tartrate | 79 | $390,319 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 17 | $377,631 |
| RytaryCarbidopa/Levodopa | 136 | $155,934 |
| AustedoDeutetrabenazine | 12 | $152,789 |
| GocovriAmantadine Hcl | 17 | $71,148 |
| FycompaPerampanel | 50 | $64,554 |
| Nurtec OdtRimegepant Sulfate | 32 | $42,847 |
| Emgality PenGalcanezumab-Gnlm | 57 | $40,124 |
| Aimovig AutoinjectorErenumab-Aooe | 40 | $33,262 |
| UbrelvyUbrogepant | 28 | $32,708 |
| QuliptaAtogepant | 27 | $30,053 |
| AptiomEslicarbazepine Acetate | 18 | $21,649 |
| Oxtellar XrOxcarbazepine | 11 | $14,406 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $70 | $960,94076 claims |
| PfizerOctagam, Nurtec Odt, Premarin | $586 | $423,20963 claims |
| Grifols USA, LLCGamunex-C | $409 | $394,09625 claims |
| Acadia Pharmaceuticals IncNuplazid | $871 | $390,31979 claims |
| Amneal Pharmaceuticals LLCRytary, Pyridostigmine Bromide | $199 | $158,812171 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $628 | $152,78912 claims |
| AbbVieUbrelvy, Qulipta, Namzaric | $2,063 | $71,29569 claims |
| MDD US Operations, LLCGocovri | $459 | $71,14817 claims |
| Eisai Inc.Fycompa | $858 | $64,55450 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $268 | $21,64918 claims |
| Supernus Pharmaceuticals, Inc.Oxtellar Xr | $270 | $14,40611 claims |
| Axsome Therapeutics, Inc.Sunosi | $78 | $10,02112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 225 neurology providers in Louisiana.
Other neurology in New Orleans
- Bridget BagertNew Orleans$1.4M
- Joseph TarsiaNew Orleans$1.2M
- Angela TraylorNew Orleans$941K
- Brian CopelandNew Orleans$304K
- John EnglandNew Orleans$268K
- Piotr OlejniczakNew Orleans$241K
- Sheryl Martin-SchildNew Orleans$106K
- Aimee AysenneNew Orleans$41K
- Caroline GoldinNew Orleans$38K
- Elizabeth CrabtreeNew Orleans$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.